SUBSCRIBE

Breaking News on Food, Beverage & Supplement Development - Asia PacificEU edition | US edition

Headlines > Business

Deal cements supply relationship for more bioavailable curcumin, quercitin out of Japan

Post a comment

By Hank Schultz

15-Aug-2014

Thera Innovations, a Canadian importer of dietary supplement ingreidients, has anounced a new supply deal for more bioavailable forms of curcumin and quercitin. The ingredients, branded as Theracumin and EMIQ, and are souced from Theravalues Corporation, a Japanese supplier.

 

“Our partnership is founded on our shared values of evidenced-based research, innovation and excellence in customer service," said John Tak, vice-president for marketing and business development for Thera Innovations Inc.

According to Thera Innovations, Theracumin utilizes a patented, natural colloidal dispersion technology to enhance bioavailability and dramatically increases curcumin levels in the blood. EMIQ (enzymatically modified isoquercitrin) is a highly bioavailable form of quercetin – a flavonoid that exerts anti-allergy effects. It has also been clinically shown to stimulate the reduction of visceral fat. 

Evidence for the anti-inflammatory efficacy of curcuminoids, dervied from turmeric root, has piled up.  But it runs up against the wall of curcumin’s very poor bioavailability in its native form.  Theravalues’ colloidal approach is one of a number in the marketplace to boost bioavailability. 

Michael Murry, ND, is director of product science and innovation for Canadian supplement manufacturer Natural Factors, one of the largest manufacturers in North America. Natual Factors is one of the companies using Theracumin in its products. Murray, an author and industry expert who has a long history of product introductions in the North American market, said the techonolgy around Theramcumin is what caught his eye.

Colloidal process

“I have really been interested in bringing many of the clincially proven natural products to North America,” Murray told NutraIngredients-USA. “When I come across ground breaking technology like Theracumin I get excited.  They use a new technolgoy where they solubalize curcumin in a vegetable gum and use a grinding process in which it becomes a colloidal suspension.”

Murray said the net result is bioavailability that is many times that of native, unprocessed curcumin powder.  That makes a critical difference in the ingredient’s effectiveness, he said.

“We are seeing a lot of researchers jump on board to do their clinical research with Theracurmin.  There are over a dozen double-blind, placebo-controlled trials underway using Theracumin.  If we look at the failure of curcumin in various clinical trials it can be traced to using forms of curcumin that don’t allow enough cucurmin to absorbed to see and particular effect,” Murray said.

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Post a comment

Comment title *
Your comment *
Your name *
Your email *

We will not publish your email on the site

I agree to Terms and Conditions

These comments have not been moderated. You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment. Any comment that violates these terms may be removed in its entirety as we do not edit comments. If you wish to complain about a comment please use the "REPORT ABUSE" button or contact the editors.

Related products

Key Industry Events

 

Access all events listing

Our events, Events from partners...